Novacyt launches IVDR-certified Yourgene Insight DPYD test in Europe

Reuters2026/09/08 11:14

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Novacyt launched the Yourgene Insight DPYD test with EU IVDR certification, expanding access to regulated European clinical genetics markets.
The assay detects 19 clinically relevant DPYD variants to help identify patients at higher risk of severe fluoropyrimidine chemotherapy toxicity.
Novacyt described it as the first IVDR CE-marked DPYD test covering all Level 1 and Level 2 variants recommended by AMP and NCCN.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Novacyt SA published the original content used to generate this news brief on September 08, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Novacyt launches IVDR-certified Yourgene Insight DPYD test in Europe

You may also like

Crypto prices